Alaina Jaster Profile picture
Aug 2 17 tweets 4 min read
Time for another #sciencetwitter journal club! Today's paper: #Microdosing with #psilocybin #mushrooms: a double-blind placebo-controlled study by Cavanna et al 2022! Hot off the presses!

nature.com/articles/s4139…
This study has:

34 participants, about half of which had previous experience with psychedelics

Randomized, double-blind placebo-controlled, within-subjects design

0.5. g psilocybin mushroom in capsule and edible, non-psychedelic mushroom as placebo
typical "microdose" is 0.1 - 0.5 g of dried mushrooms, which still can produce some type of altered consciousness, hallucination effect depending on the person.

most common regimen is 1 day on 2 days off, based on Fadiman's work.
Methods:
EEG, and VAS - adadpted protocol from Carhart-harris

3 tasks to assess convergent and divergent thinking

12 questionnaires to assess anxiety, suggestibility, stress, well-being, empathy, cognitive flextibility + more

auditory stimulation responses & physical activity
Increased VAS total scores were found in the “unblinded” subset but not in the “blinded” one.

Meaning, the increased ratings for things like intensity of trip, positive mood, ego-dissolution, emotional arousal was increased in the group who figured out they were taking shrooms
Most of the items for VAS were found to be inconclusive once corrected for multiple comparisons, thus authors did not find robust evidence of consistent changes in the VAS sub-items across participants
No differences in self-reported scales and questionnaires between placebo and microdose.

Meaning, microdose had little effect on participant self-scoring their own mood, anxiety, stress, well-being, etc.
There were also no conclusive differences seen in creativity tasks on divergent and convergent thinking between placebo and microdose.
In tests on perception and cognition, the only noted effect was psilocybin group had an increase response time to the Stroop task, which is a task to name the ink color of a color word if there is a mismatch between ink color and word
No significant differences were found in tests to assess auditory perception or in monitoring of physical activity.
For EEG, they did report decreased EEG power in the theta band under psilocybin, which is "consistent with the broadband spectral power reductions reported for higher doses."
One issue with microdosing is that there is no standardized procedure, so it's difficult to understand whether these are actual microdoses, what the optimal regimen would be, etc. This needs to be determined if it becomes a true medical practice.
Positivity bias, outcome and expectation bias can all lead to issues in anecdotal reports of microdosing.

This leads to a STRONG placebo effect, which is why it's important to do blinded studies.
Other studies on microdosing have reported positive effects on the primary outcome of their respective studies; however, these results could be explained by breaking of the placebo condition.

Similar to the present study of 75% unblinding, other studies report 60% unblinding
Limitations:

need more participants to power study
weight-adjusted doses
purity of mushroom capsules
two doses per week - 2 weeks, sometimes microdosing is longer
need future studies to determine long-term effects on mood/overall health and wellbeing
Summary:

Positive effects of microdosing (0.5 g) of psilocybin mushrooms is mainly attributed to placebo effect

No major changes in mood, cognition, well-being, physical activity, etc.

Another piece of evidence that microdosing is most-likely placebo, but more studies needed!
Would also like to add... 0.5 is not a microdose, but this dose was used because it's at the higher end of the self-reported doses that would be easily quantifiable.

Interested to see more double blind placebo studies with 0.1 to 0.05 doses

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Alaina Jaster

Alaina Jaster Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @JasterAlaina

Jul 30
Re-sharing the survey I made to assess the needs of those who have experienced SUDs or addiction-related issues. The goal is to get 100 participants to see what has been helpful interventions and how we can better inform clinical/preclinical research!
redcap.vcu.edu/surveys/?s=L4R…
If you work with patients, are someone who has struggled with addiction yourself, or knows someone who would be willing to participate please share the link with them! It's completely anonymous and IRB approved 😀 We have 50 participants so far and need 50 more by December!
The survey will take 5-10 minutes. This voluntary survey aims to collect demographic information, information about experiences in recovery, abstinence from use, drug of choice and other specifics associated with use. IF you have already taken it, thank you!
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(